Quantcast

Latest Pharmaceutical industry in India Stories

2014-06-02 08:31:48

CRANBURY, N.J., June 2, 2014 /PRNewswire/ -- Ipca Laboratories Ltd., India (Ipca) and Oncobiologics, Inc., USA (Oncobiologics) announced today the creation of a two-part alliance for the development, manufacture and commercialization of biosimilar monoclonal antibody products. Under the first part of the agreement, Ipca will in-license and commercialize biosimilar products for the India and associated markets. These products will be developed by Oncobiologics to US FDA and EU...

2014-06-02 08:30:00

Firm Adds Significantly to Strength of Biotech Investment Team BOSTON, SAN FRANCISCO and LONDON, June 2, 2014 /PRNewswire/ -- SV Life Sciences ("SVLS"), a leading international life sciences venture capital firm, today announced the appointments of Dan Burgess, Dr. Ed Mascioli and Dr. Michael Mendelsohn as new venture partners. All three new venture partners will join SVLS' biotechnology investment team, a highly experienced group investing in truly innovative medicines, platform...

2014-06-02 08:29:05

CALGARY, June 2, 2014 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will participate in the Jefferies 2014 Global Healthcare Conference in a session on Tuesday June 3(rd), 2014 at 4:00 p.m. ET. The conference takes place from June 2(nd) to 5(th) in New York, NY. A live audio link to the webcast session will be available at: http://wsw.com/webcast/jeff82/ONCY or on the company's website at...

2014-05-28 20:20:50

LONDON, May 28, 2014 /PRNewswire/ -- Imperial Innovations Group plc (AIM:IVO, 'Innovations'), the leading technology commercialisation and investment company and S.R.One Ltd, GlaxoSmithKline's venture captial fund, announce today that they have led, alongside co-investor UCL Business PLC (UCLB), an GBP850,000 seed financing for Puridify, a newly formed company providing purification solutions for biotherapeutic manufacturing. Puridify's technology was developed in the...

2014-05-27 12:32:32

LONDON, May 27, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Diabetic Nephropathy Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/diseases/global_diabetic_nephropathy_market_2014_2018.html About Diabetic NephropathyDiabetic nephropathy is a disease of the kidney glomerulus, which is caused by high blood sugar. When diabetes damages kidneys, which contain millions of tiny blood vessel clusters (glomeruli) that filter waste from the...

2014-05-27 08:28:11

NESS ZIONA, Israel, May 27, 2014 /PRNewswire/ -- Mapi Pharma Ltd. ("Mapi" or the "Company"), a developer of high-barrier to entry and high value-added generic drugs, announced today that its US patent for the company's Glatiramer Acetate Depot has been extended until December 2030. The notice of allowance for US Patent Application No. 13/258,808 entitled Depot Systems Comprising Glatiramer or Pharmacologically Acceptable Salt Thereof, also awarded additional claims to...

2014-05-23 04:20:53

LONDON, May 23, 2014 /PRNewswire/ -- New Company Created to be a Leading Provider of Technologies and Services to Enable Better Biopharmaceuticals - PolyTherics and Antitope to continue to trade as wholly owned subsidiaries of Abzena - New brand highlights depth and range of offering to the global biopharmaceutical industry - Abzena to establish headquarters in Cambridge, UK PolyTherics Limited ("PolyTherics"), a...

2014-05-20 12:28:25

LONDON, May 20, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Dermatological Drugs Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/therapeutic/global_dermatological_drugs_market_2014_2018.html TechNavio's analysts forecast the Global Dermatological Drugs market to grow at a CAGR of 4.29 percent over the period 2013-2018. One of the key factors contributing to this market's growth is an increase in the aging population worldwide....

2014-05-13 23:03:29

More companies are projected to enter the industry over the period; nonetheless, growth will be hindered by increasing government regulation, which is expected to raise costs for industry operators. For this reason, industry research firm IBISWorld has updated a report on the Inorganic Chemical Manufacturing industry in its growing industry report collection. New York, NY (PRWEB) May 13, 2014 Inorganic chemicals are primarily used as intermediary additives to products such as detergents,...

2014-05-09 20:23:13

DUBLIN, May 10, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/xrtmp7/global) has announced the addition of the "Global Biosimilars Market 2014-2018" [http://www.researchandmarkets.com/research/xrtmp7/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The analysts forecast the Global Biosimilars Market to grow at a CAGR of 27.58 percent over the period 2013-2018. One of the key...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.